WHO ties up with Biological E. Limited for vaccine manufacturing

A few companies in India have manufactured Covid-19 vaccines in India. One such company from Hyderabad is Biological E. Limited. As informed by some of the senior officials on Monday, the company has been selected by the World Health Organization to receive technology transfer on mRNA Covid-19 vaccines.

It was highlighted that the advisory committee of the WHO on Vaccine Product Development selected the firm after a detailed examination of a number of proposals from India, as recipients of mRNA technology from the global health body's technology transfer hub. WHO along with its partners will work with the Indian Government and BE to develop a proper way of preparation of the desired vaccine.

The managing director of Biological E said that this will be helpful in the development of new vaccines in the future. Renowned company BE has been investing in mRNA technologies since the last year.

The Messenger RNA or mRNA vaccines teach our cells how to make a protein that will trigger an immune response inside our bodies

The Messenger RNA (mRNA) vaccines teach our cells how to make a protein that will trigger an immune response inside our bodies. Like all vaccines, mRNA vaccines benefit people who get vaccinated by giving them protection against diseases like COVID-19 without risking the potentially serious consequences of getting sick.

The Messenger RNA or mRNA vaccines teach our cells how to make a protein that will trigger an immune response inside our bodies. Like all vaccines, mRNA vaccines benefit people who get vaccinated by giving them protection against diseases like COVID-19 without risking the potentially serious consequences of getting sick.

The mRNA vaccines are newly available to the public. However, researchers have been studying and working with mRNA vaccines for decades. CDC recommends that people who are starting their vaccine series or getting a booster dose get either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines). The mRNA vaccines are preferred over Johnson & Johnson's Janssen COVID-19 vaccine in most circumstances, but the J&J/Janssen COVID-19 vaccine may be considered in some situations.